Proteomics Approaches to Define Senescence Heterogeneity and Chemotherapy Response - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Proteomics Year : 2019

Proteomics Approaches to Define Senescence Heterogeneity and Chemotherapy Response

Abstract

In primary cells, senescence induces a permanent proliferative arrest to prevent the propagation of malignant cells. However, the outcome of senescence is more complex in advanced cancer cells where senescent states are heterogeneous. Here, this heterogeneity is discussed and it is proposed that proteomic analysis should be used to identify specific signatures of cancer cells that use this pathway as an adaptive mechanism. Since senescent cells produce an inflammatory secretome, MRM approaches and quantification with internal standards might be particularly suited to follow the expression of the corresponding markers in body fluids. Used in combination with imaging medical technics, a better characterization of senescence heterogeneity should help to monitor the response to chemotherapy treatment.

Domains

Cancer
Embargoed file
Embargoed file
Visibility date is undetermined
Loading...

Dates and versions

inserm-02140239 , version 1 (27-05-2019)

Identifiers

Cite

Coralie Petit, Jordan Guillon, Bertrand Toutain, Alice Boissard, Anne Patsouris, et al.. Proteomics Approaches to Define Senescence Heterogeneity and Chemotherapy Response. Proteomics, 2019, pp.1800447. ⟨10.1002/pmic.201800447⟩. ⟨inserm-02140239⟩
171 View
2 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More